The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Richard K. Bogan,1 Emmanuel Mignot,2 Yves Dauvilliers,3 Ronald R. Grunstein,4,5 Gert Jan Lammers,6,7 David T. Plante,8 Rafael del Río Villegas,9,10 Feng Miao,11 Bikram Kabir,11 Juan Chavez,11 Bhaskar Rege,11 Craig Hopkinson,11 Julie Himes,11 Giuseppe Plazzi12,13
1University of South Carolina School of Medicine, Columbia, SC, USA; 2Stanford Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Stanford, CA, USA; 3Sleep Unit, Gui de Chauliac Hospital, University of Montpellier, INSERM Institute for Neurosciences of Montpellier, Montpellier, France; 4Woolcock Institute of Medical Research, Macquarie University, Sydney, Australia; 5Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia; 6Leiden University Medical Center, Leiden, the Netherlands; 7Stichting Epilepsie Instellingen Nederland, Sleep-Wake Centre, Heemstede, the Netherlands; 8University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, USA; 9Neurophysiology and Sleep Disorders Unit, Vithas Madrid Hospitals, Madrid, Spain; 10Departamento de Ciencias Médicas Clínicas, Universidad CEU San Pablo, CEU Universities, Madrid, Spain; 11Alkermes, Inc., Waltham, MA, USA; 12IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; 13University of Modena and Reggio-Emilia, Modena, Italy
